StonvexLoading…
StonvexStonvexStonvexCore line items from VENU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $17.90M | $17.83M | $12.60M |
Operating Income | $-46.13M | $-27.38M | $-11.13M |
Net Income | $-44.09M | $-30.34M | $-10.52M |
EPS (Diluted) | $-1.10 | $-0.86 | Not available |
Total Assets | $370.56M | $178.42M | $83.22M |
Total Liabilities | $171.70M | $47.60M | $21.24M |
Cash & Equivalents | $41.31M | $37.97M | $20.20M |
Free Cash Flow OCF − CapEx | $-134.01M | $-68.73M | $-36.04M |
Shares Outstanding | 42.86M | 37.47M | 0 |